We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The World Health Organization has released a draft update to its guidelines for API and finished drug stability testing, that says it reflects how stability testing has evolved since the release of the original in 2009. Read More
Despite the Senate defeat of a measure allowing drug importation just a month ago, House and Senate Democrats are trying again: they’ve introduced new legislation that would allow imports of prescription drugs from Canada. Read More
Pfizer’s Hospira is drawing scrutiny from the FDA in a warning letter for failing to fully investigate quality defects, such as the presence of cardboard, in batches of injections and neglecting to take corrective measures. Read More
Pharmaceutical executives from the nation’s leading firms are urging Congressional leaders to pass a Republican-led tax reform that would allow companies to pay lower taxes. Read More
A California lawmaker introduced a bill that would prohibit pharmaceutical companies from issuing certain prescription drug discounts or coupons to consumers in the state. Read More
Pfizer is the latest drugmaker to reveal that it received subpoenas requesting information on the company’s relationship with nonprofit organizations that curb the prices of costly drugs through financial assistance programs. Read More